Phase II clinical trial of S-1 plus nanoparticle albumin-bound paclitaxel as first-line chemotherapy for patients with metastatic gastric cancer

被引：0
|
作者：
Xu, Rui-hua
He, Ming-ming
Zhang, Dong-sheng
Wang, Feng
Jin, Ying
机构：
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2016年 / 34卷 / 15期
关键词：
D O I：
10.1200/JCO.2016.34.15_suppl.4049
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4049
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Phase II clinical trial of S-1 plus nanoparticle albumin-bound paclitaxel in untreated patients with metastatic gastric cancer
    He, Ming-ming
    Wang, Feng
    Jin, Ying
    Yuan, Shu-qiang
    Ren, Chao
    Luo, Hui-yan
    Wang, Zhi-qiang
    Qiu, Miao-zhen
    Wang, Zi-xian
    Zeng, Zhao-lei
    Li, Yu-hong
    Wang, Feng-hua
    Zhang, Dong-sheng
    Xu, Rui-hua
    CANCER SCIENCE, 2018, 109 (11) : 3575 - 3582
  • [2] Camrelizumab plus albumin-bound paclitaxel and S-1 as first-line treatment of advanced gastric/gastroesophageal junction cancer: A phase II clinical trial
    Hou, X. F.
    Li, S.
    Wu, C.
    Liu, J.
    ANNALS OF ONCOLOGY, 2023, 34 : S866 - S867
  • [3] Phase II Multicenter Trial of Albumin-Bound Paclitaxel and Capecitabine in First-Line Treatment of Patients With Metastatic Breast Cancer
    Schwartzberg, Lee S.
    Arena, Francis P.
    Mintzer, David M.
    Epperson, Amanda L.
    Walker, Mark S.
    CLINICAL BREAST CANCER, 2012, 12 (02) : 87 - 93
  • [4] Phase II trial of nab-paclitaxel (nanoparticle albumin-bound paclitaxel (ABX)) plus capecitabine (XEL) in first-line treatment of metastatic breast cancer (MBC)
    Somer, B. G.
    Schwartzberg, L. S.
    Arena, F.
    Epperson, A.
    Fu, D.
    Fortner, B. V.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [5] SAFETY AND EFFICACY OF ALBUMIN-BOUND PACLITAXEL AND OXALIPLATIN AND S-1 AS FIRST-LINE TREATMENT OF PATIENTS WITH ADVANCED GASTRIC CANCER
    Lou, H.
    Pan, H.
    Pan, Q.
    Li, D.
    Jin, W.
    ANNALS OF ONCOLOGY, 2012, 23 : 256 - 256
  • [6] Phase II trial of nanoparticle albumin-bound paclitaxel as second-line chemotherapy for unresectable or recurrent gastric cancer
    Sasaki, Yasutsuna
    Nishina, Tomohiro
    Yasui, Hirofumi
    Goto, Masahiro
    Muro, Kei
    Tsuji, Akihito
    Koizumi, Wasaburo
    Toh, Yasushi
    Hara, Takuo
    Miyata, Yoshinori
    CANCER SCIENCE, 2014, 105 (07) : 812 - 817
  • [7] A phase II trial of oxaliplatin plus S-1 as a first-line chemotherapy for patients with advanced gastric cancer
    Yang Lin
    Song Yan
    Zhou Ai-ping
    Qin Qiong
    Chi Yihebali
    Huang Jing
    Wang Jin-wan
    CHINESE MEDICAL JOURNAL, 2013, 126 (18) : 3470 - 3474
  • [8] A phase II study of biweekly S-1 and paclitaxel (SPA) as first-line chemotherapy in patients with metastatic or advanced gastric cancer
    Haiping Jiang
    Jiong Qian
    Peng Zhao
    Xiaochen Zhang
    Yi Zheng
    Chenyu Mao
    Yulong Zheng
    Linghong Chen
    Yao Wang
    Haibo Mou
    Weijia Fang
    Lisong Teng
    Nong Xu
    Cancer Chemotherapy and Pharmacology, 2015, 76 : 197 - 203
  • [9] A phase II study of biweekly S-1 and paclitaxel (SPA) as first-line chemotherapy in patients with metastatic or advanced gastric cancer
    Jiang, Haiping
    Qian, Jiong
    Zhao, Peng
    Zhang, Xiaochen
    Zheng, Yi
    Mao, Chenyu
    Zheng, Yulong
    Chen, Linghong
    Wang, Yao
    Mou, Haibo
    Fang, Weijia
    Teng, Lisong
    Xu, Nong
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2015, 76 (01) : 197 - 203
  • [10] A phase Ⅱ trial of oxaliplatin plus S-1 as a first-line chemotherapy for patients with advanced gastric cancer
    YANG Lin
    SONG Yan
    ZHOU Ai-ping
    QIN Qiong
    CHI Yihebali
    HUANG Jing
    WANG Jin-wan
    中华医学杂志（英文版）, 2013, 126 (18) : 3470 - 3474
12345